EA201892365A1 - Составы и композиции шеллачных микрокапсул - Google Patents

Составы и композиции шеллачных микрокапсул

Info

Publication number
EA201892365A1
EA201892365A1 EA201892365A EA201892365A EA201892365A1 EA 201892365 A1 EA201892365 A1 EA 201892365A1 EA 201892365 A EA201892365 A EA 201892365A EA 201892365 A EA201892365 A EA 201892365A EA 201892365 A1 EA201892365 A1 EA 201892365A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
microcapsules
shell external
shellac
layers
Prior art date
Application number
EA201892365A
Other languages
English (en)
Inventor
Георг Ветциг
Карин Шварц
Юлия Кепплер
Ева-Мария Тайсманн
Йорг Книпп
Марк Элльрихманн
Штефан Шрайбер
Original Assignee
Конарис Рисерч Инститьют Аг
Кристиан-Альбрехтс-Универзитет Цу Киль
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Конарис Рисерч Инститьют Аг, Кристиан-Альбрехтс-Универзитет Цу Киль filed Critical Конарис Рисерч Инститьют Аг
Publication of EA201892365A1 publication Critical patent/EA201892365A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

Настоящее изобретение относится к микрокапсулам, содержащим сердцевину, содержащую активное вещество, которые характеризуются системой слоя покрытия, содержащей два слоя шеллака и pH-модулирующее вещество, предоставленное между двумя слоями шеллака.
EA201892365A 2016-04-19 2017-04-12 Составы и композиции шеллачных микрокапсул EA201892365A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16165990 2016-04-19
PCT/EP2017/058741 WO2017182350A1 (en) 2016-04-19 2017-04-12 Shellac microcapsule formulations and compositions

Publications (1)

Publication Number Publication Date
EA201892365A1 true EA201892365A1 (ru) 2019-03-29

Family

ID=55794879

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892365A EA201892365A1 (ru) 2016-04-19 2017-04-12 Составы и композиции шеллачных микрокапсул

Country Status (8)

Country Link
US (1) US20190105278A1 (ru)
EP (1) EP3445336B1 (ru)
JP (1) JP2019515917A (ru)
CN (1) CN109069427A (ru)
AU (1) AU2017253527A1 (ru)
CA (1) CA3021518A1 (ru)
EA (1) EA201892365A1 (ru)
WO (1) WO2017182350A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111867583A (zh) * 2018-01-18 2020-10-30 学校法人庆应义塾 治疗溃疡性大肠炎的胶囊剂
JP7368383B2 (ja) 2018-05-14 2023-10-24 キャプシュゲル・ベルジウム・エヌ・ヴィ 不透明化剤を含むカプセル
EP3977865A4 (en) * 2019-05-28 2023-02-01 Toymedical Co., Ltd. SODIUM EXCRETION PARTICLES
US20220257521A1 (en) * 2019-06-14 2022-08-18 Folium Biosciences Europe B.V. Method for micro-encapsulation of natural ingredients by means of contacting with supercritical gas
CN111359553B (zh) * 2020-03-12 2022-04-01 蚌埠学院 一种生物降解食用色素微胶囊的制备方法
EP4289275A1 (en) * 2022-06-07 2023-12-13 Universität für Bodenkultur Wien Insect repellent composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819822A (en) * 1969-12-18 1974-06-25 Kowa Co Diagnostic agent for detection of primary hepatoma
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
US6620431B1 (en) * 2000-04-17 2003-09-16 Charles Signorino Shellac film coatings providing release at selected pH and method
EA200970708A1 (ru) * 2007-01-24 2010-02-26 Др. Редди`С Лабораторис Лтд. Фармацевтические композиции, включающие аторвастатин и никотиновую кислоту
CN102170871B (zh) * 2008-07-31 2013-04-17 费伊肯有限公司 微胶囊化物及其制备方法
IT1398643B1 (it) 2010-03-04 2013-03-08 Cosmo Technologies Ltd Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa
CA2858915C (en) * 2011-12-16 2020-10-27 Construction Research & Technology Gmbh Shellac-coated particles of active ingredients with controlled release properties at high ph-values, process for their manufacture and use thereof
CA2881370C (en) 2012-08-07 2020-08-25 Nippon Paint Co., Ltd. Luster coating composition, method for producing multi layered coating film therewith, and multi layered coating film

Also Published As

Publication number Publication date
WO2017182350A1 (en) 2017-10-26
US20190105278A1 (en) 2019-04-11
CN109069427A (zh) 2018-12-21
EP3445336A1 (en) 2019-02-27
AU2017253527A1 (en) 2018-11-01
CA3021518A1 (en) 2017-10-26
EP3445336B1 (en) 2020-10-28
JP2019515917A (ja) 2019-06-13

Similar Documents

Publication Publication Date Title
EA201892365A1 (ru) Составы и композиции шеллачных микрокапсул
BR112017012068A2 (pt) composições fornecendo liberação retardada de ativos
PH12018500718A1 (en) Compounds useful as modulators of trpm8
MA44008A (fr) 1,2,3-triazoles substitués utilisés comme modulateurs de nmda sélectifs de nr2b
MX2015015129A (es) Microencapsulacion de enzimas detergentes.
MX2018006148A (es) Inhibidores de cxcr2.
UY36275A (es) Compuestos aminopirimidinilo
CO2017011553A2 (es) Sal de (s)-csa de s-ketamina, sal de (r)-csa de s-ketamina y procesos para la preparación de s-ketamina
CY1124761T1 (el) Ρυθμιστες της δραστικοτητας του συμπληρωματος
DK3067817T3 (da) Dynamisk data-maskering til mainframe-applikation
MX2022013454A (es) Moduladores de la actividad del complemento.
MX2016016114A (es) Microcapsulas de perfume hibridas.
DK3713665T3 (da) Fremgangsmåde til fremstilling af kapsler dannet af en udvendig, tværbundet hydrogenkappe, der omgiver en central kerne
MA41453A (fr) Encapsulation d&#39;agents actifs très puissants
DK3458467T3 (da) Fremgangsmåde til 6,7-alfa-epoxidering af steroid-4,6-diener
FI20165456A (fi) Kommunikaatiopalvelun hankinta
EA201791113A1 (ru) Фармацевтические составы в виде гранул, содержащие диметилфумарат
EA201792262A1 (ru) Пироглутамат вортиоксетина
DK3844161T3 (da) Heteroaromatiske forbindelser som vanininhibitorer.
EP3697922A4 (en) PREDICTION OF AN ACTIVE SET OF COMPOUNDS WITH ALTERNATIVE CORES
EA201691999A1 (ru) Новые сульфониламинобензамидные соединения
EA201890828A1 (ru) Оптимизированная таблетка с высокой дозой активного соединения, содержащая месалазин
MY196462A (en) Semiconductor Encapsulant
EA201891717A1 (ru) Препараты мультигеномных ретровирусных векторов и способы и системы для их получения и применения
EP3345398A4 (en) DYNAMIC GENERATION OF ENRICHMENT MODE DATA